Review: taking Lovenox and Flagyl together


Summary

Drug interactions are reported among people who take Lovenox and Flagyl together. This review analyzes the effectiveness and drug interactions between Lovenox and Flagyl. It is created by eHealthMe based on reports of 1,497 people who take the same drugs from FDA and social media, and is updated regularly.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Lovenox

Lovenox has active ingredients of enoxaparin sodium. It is often used in deep venous thrombosis. (latest outcomes from Lovenox 26,573 users)

Flagyl

Flagyl has active ingredients of metronidazole. It is often used in crohn's disease. (latest outcomes from Flagyl 14,732 users)

On Sep, 19, 2016

1,497 people who take Lovenox, Flagyl are studied.


Number of reports submitted per year:

Lovenox and Flagyl drug interactions.

Drug effectiveness over time:

Lovenox:
  • < 1 month: 0.0% - (0 of 1 people)
  • 1 - 6 months: 100.0% - (1 of 1 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Flagyl:
  • < 1 month: 0.0% - (0 of 3 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Lovenox:
  • female: 100.0% - (1 of 1 people)
  • male: 0.0% - (0 of 1 people)
Flagyl:
  • female: 0.0% - (0 of 2 people)
  • male: 0.0% - (0 of 1 people)

Drug effectiveness by age:

Lovenox:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 100.0% - (1 of 1 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 1 people)
  • 60+: 0.0% - (0 of 0 people)
Flagyl:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 1 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 1 people)
  • 60+: 0.0% - (0 of 1 people)

Most common drug interactions over time *:

< 1 month:
  • thrombocytopenia
  • renal failure acute
  • febrile neutropenia
  • pancytopenia
  • neutropenia
  • pulmonary embolism
  • cholestasis
  • diarrhoea
  • pyrexia
  • anaemia
1 - 6 months:
  • neutropenia
  • pulmonary embolism
  • abscess
  • diverticular perforation
  • emotional distress
  • abdominal pain
  • agranulocytosis
  • blister
  • contusion
  • deep vein thrombosis
6 - 12 months:
  • febrile neutropenia
  • leukopenia
  • pyrexia
2 - 5 years:
  • pain
  • abdominal pain upper
  • brain cancer metastatic
  • cardiogenic shock
  • crohn's disease
  • cytomegalovirus infection
  • death
  • dermatitis exfoliative
  • hepatic cancer metastatic
  • injury
not specified:
  • pain
  • anxiety
  • injury
  • pyrexia
  • asthenia
  • anaemia
  • osteonecrosis of jaw
  • anhedonia
  • dyspnoea
  • depression

Most common drug interactions by gender *:

female:
  • pain
  • anxiety
  • injury
  • asthenia
  • osteonecrosis of jaw
  • anaemia
  • pyrexia
  • depression
  • anhedonia
  • urinary tract infection
male:
  • pain
  • anxiety
  • pyrexia
  • injury
  • thrombocytopenia
  • nausea
  • diarrhoea
  • anaemia
  • dyspnoea
  • hypotension

Most common drug interactions by age *:

0-1:
  • abasia
  • aphasia
  • developmental delay
  • drug withdrawal syndrome neonatal
  • foetal arrhythmia
  • respiratory distress
  • tremor
  • liver function test abnormal
  • drug dependence
  • foetal exposure during pregnancy
2-9:
  • depressed level of consciousness
  • drug ineffective
  • cholestasis
  • muscular weakness
  • pancreatitis
  • pruritus generalised
  • rash generalised
  • rash morbilliform
  • abdominal pain
  • abnormal behaviour
10-19:
  • neutropenia
  • abdominal pain
  • disease progression
  • headache
  • alanine aminotransferase increased
  • ascites
  • aspartate aminotransferase increased
  • blood alkaline phosphatase increased
  • blood bilirubin increased
  • hepatocellular carcinoma
20-29:
  • deep vein thrombosis
  • pulmonary embolism
  • pain
  • injury
  • mass
  • renal failure acute
  • anhedonia
  • anxiety
  • asthenia
  • back pain
30-39:
  • pain
  • asthenia
  • aspartate aminotransferase increased
  • anxiety
  • injury
  • muscle spasms
  • type 2 diabetes mellitus
  • alanine aminotransferase increased
  • anhedonia
  • dyskinesia
40-49:
  • pain
  • anxiety
  • pyrexia
  • nausea
  • anaemia
  • pain in jaw
  • dyspnoea
  • oedema peripheral
  • sinusitis
  • injury
50-59:
  • pain
  • anxiety
  • injury
  • anaemia
  • anhedonia
  • pyrexia
  • emphysema
  • atelectasis
  • intervertebral disc protrusion
  • oedema peripheral
60+:
  • anxiety
  • pain
  • injury
  • asthenia
  • anaemia
  • diarrhoea
  • dyspnoea
  • pyrexia
  • osteoarthritis
  • deep vein thrombosis

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Lovenox and Flagyl?

Can you answer these questions?

More questions for: Lovenox, Flagyl

You may be interested in these reviews

More reviews for: Lovenox, Flagyl

On eHealthMe, Lovenox (enoxaparin sodium) is often used to treat deep venous thrombosis. Flagyl (metronidazole) is often used to treat crohn's disease. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.